Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Fund Novel Imaging Probe Technology Studies

NEW YORK (GenomeWeb News) – The National Institute of Biomedical Imaging and Bioengineering is seeking to fund research into novel imaging methods that can detect and create images of in vivo molecular activities, under a follow-up to an earlier request under the National Institutes of Health’s Roadmap for Medical Research program.
Researchers could use this funding to develop imaging approaches for studying markers and function of normal cells in control human subjects and patients, and for imaging markers and biochemical or physiological abnormalities of disease cells in patients.
The funding levels NIH will grant for these studies will vary in size and duration depending on the scope and nature of the proposed research.
As with other Roadmap programs, NIH wants to support innovative “high impact” approaches, instead of the incremental technology development programs already being supported.
NIH’s research objectives include developing molecular imaging probes using novel concepts that are highly specific, sensitive, and which can be applied to clinical situations. The technology also could develop tools that target a wide range of normal cells such as quantitating and characterizing viable pancreatic beta cells in type-1 diabetes, discriminating brown fat mass and metabolic activity from metabolism in surrounding tissue, and identifying non-invasive signatures of neuronal plasticity.
The investigators also could develop imaging technologies that target biological processes that might provide early markers for a range of diseases such as inflammation, fibrosis, activation of immune cells, alterations in gene expression pathways, signal transduction pathways, and post-translational modifications of proteins.
More information about the program is available here.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.